Cell and Genera Meeting 2023

Glycostem CEO Troels Jordansen is going to attend the Cell and Genera Meeting 2023, taken place on 12th to 14th April in Barcelona, Spain.

Innate Killer Summit 2023

Glycostem is going to participate Innate Killer Summit 2023, taken place on 28 - 30 March 2023 in San Diego, US.
Wednesday, 29 March 2023
14:30 Panel Discussion: Optimizing Innate Therapy in the Clinic
Kai Pinkernell, CMO, Glycostem

14:30 Panel Discussion: Sharing a Vision of the Future for Commercial Scale Manufacturing of Innate Immune Cells
Volker Huppert, CDO, Glycostem

15:15 Driving GMP Readiness with Scalable Manufacturing Platforms & Second Sourcing Strategies with GMP Materials
Volker Huppert, CDO, Glycostem

17:10 From Europe to the US: Sharing an Expert’s Guide to Regulatory Success in Europe, & Differences Identified in FDA Processes
Kai Pinkernell, CMO, Glycostem

Bio-Europe Spring 2023

Glycostem CEO Troels Jordansen is going to participate Bio-Europe Spring 2023.

The seventeenth annual BIO-Europe Spring® premier springtime partnering conference is back in-person and will be taking place  20–22 March, 2023 in Basel, Switzerland.

Advanced Therapies 2023

Glycostem CEO Troels Jordansen is going to speak at the Advanced Therapies 2023, taken place on 14th and 15th March in London.

2nd Allogeneic Cell Therapies Summit Europe

Glycostem is going to attend the 2nd Allogeneic Cell Therapies Summit Europe in London.

31st January, 2023

16:30 GMT Maximising the Inherent Benefits of NK Cells to Effectively Target Solid Tumours

Presented by Jan Spanholtz, Chief Scientific Officer

• Capturing the intrinsic advantages of natural killer cells to infiltrate the solid tumour microenvironment
• Reflecting on NK cells anti GvHD functions to realise their full potential in allogeneic therapies
• Unlocking off-the-shelf NKs through effective and efficient large-scale manufacturing

1st February, 2023

12.30 GMT Optimising Manufacturing and Utilising Cryopreservation to Increase Allogeneic Product Shelf Life
Presented by Volker Huppert, Chief Development Officer

• Harnessing the potential of frozen products to reduce cost of goods and increase accessibility
• Optimising cryopreservation protocol to prevent decreases in quality, stability, and potency
• Employing frozen material to address scale and logistical challenges

Advanced Therapies Week 2023

Glycostem CEO Troels Jordansen is going to participate the Advanced Therapies Week 2023 in Miami, US from 18th to 20th Jan 2023.

Day 1 - January 18 2023
Think Locally, Source Globally: Are Your Products Region-Fixed or Trans-Continental?
Chairman to disucssion
3:30–5:00pm EST

Day 2 - January 19 2023
Storage and Preservation to Maintain High-Quality Raw Materials and Therapeutics
1:30–3:00pm EST

Day 3 - January 20 2023
Disruptive and Novel Therapeutics for Oncology Indications
9:00–10:30am EST